Association between Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment

Marta Monti; Tiziano Martini; Vittorio Pengo; Giovanni Poletti; Paola Pedrazzi; Chiara Biasoli; Maddalena Giovacchini; Tommaso Fasano

doi:10.1055/s-0043-1762577

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2023; 49(05): 558-560
DOI: 10.1055/s-0043-1762577

Letter to the Editor

Association between Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment

Marta Monti‡^*

¹Clinical Pathology Unit, Hub Laboratory, AUSL della Romagna, Cesena, Italy

,

Tiziano Martini‡^*

²Immuno-Haematology and Transfusion Medicine, Center for Congenital Bleeding Disorders, Cesena General Hospital, Cesena, Italy

,

Vittorio Pengo

³Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padova, Padova, Italy

⁴Arianna Foundation on Anticoagulation, Bologna, Italy

,

Giovanni Poletti

¹Clinical Pathology Unit, Hub Laboratory, AUSL della Romagna, Cesena, Italy

,

Paola Pedrazzi

²Immuno-Haematology and Transfusion Medicine, Center for Congenital Bleeding Disorders, Cesena General Hospital, Cesena, Italy

,

Chiara Biasoli

²Immuno-Haematology and Transfusion Medicine, Center for Congenital Bleeding Disorders, Cesena General Hospital, Cesena, Italy

,

Maddalena Giovacchini

¹Clinical Pathology Unit, Hub Laboratory, AUSL della Romagna, Cesena, Italy

,

Tommaso Fasano

¹Clinical Pathology Unit, Hub Laboratory, AUSL della Romagna, Cesena, Italy

References
1 Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003; 101 (05) 1827-1832
2 Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 1983; 61 (04) 684-692
3 Sarker T, Roy S, Hollon W, Rajpurkar M. Lupus anticoagulant acquired hypoprothrombinemia syndrome in childhood: two distinct patterns and review of the literature. Haemophilia 2015; 21 (06) 754-760
4 Mulliez SM, De Keyser F, Verbist C. et al. Lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature. Lupus 2015; 24 (07) 736-745
5 Sakamoto A, Ogura M, Hattori A. et al. Lupus anticoagulant hypoprothrombinemia syndrome associated with bilateral adrenal haemorrhage in a child: early diagnosis and intervention. Thromb J 2021; 19 (01) 19
6 Brblić T, Brčić K, Margetić S, Čaržavec D, Gaćina P, Bogdanić N. Lupus anticoagulant-hypoprothrombinemia syndrome with severe bleeding diathesis after coronavirus disease 2019: a case report. Croat Med J 2022; 63 (05) 490-494
7 Favaloro EJ, Henry BM, Lippi G. Is lupus anticoagulant a significant feature of COVID-19? A critical appraisal of the literature. Semin Thromb Hemost 2022; 48 (01) 55-71
8 Favaloro EJ, Henry BM, Lippi G. COVID-19 and antiphospholipid antibodies: time for a reality check?. Semin Thromb Hemost 2022; 48 (01) 72-92